Percheron Therapeutics LimitedASX: PER

ATL1102 DMD Paediatric Investigation Plan submitted to EMA

Feb 25, 2021 at 3:08 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment